{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:15Z","timestamp":1776329775750,"version":"3.50.1"},"reference-count":12,"publisher":"Baskent University","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.6002\/ect.2022.0261","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T07:58:21Z","timestamp":1671436701000},"page":"1022-1030","source":"Crossref","is-referenced-by-count":1,"title":["A Comparative Study on the Variation in Seropositivity Rates After 2-Dose COVID-19 Vaccination Before or After Transplant: A Single-Center Analysis"],"prefix":"10.6002","volume":"20","author":[{"given":"Hideki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Unagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Yagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"References"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"1. Ishida H, Furusawa M, Unagami K, Omoto K, Iizuka J, Takagi T. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a retrospective cohort study at a single transplant institute in Japan. Exp Clin Transplant. 2022;20(5):463-471. doi:10.6002\/ect.2022.0020","DOI":"10.6002\/ect.2022.0020"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"2. Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105(1):37-55. doi:10.1097\/TP.0000000000003523","DOI":"10.1097\/TP.0000000000003523"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"3. Rincon-Arevalo H, Choi M, Stefanski AL, et al. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol. 2021;6(60). doi:10.1126\/sciimmunol.abj1031","DOI":"10.1126\/sciimmunol.abj1031"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"4. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325(21):2204-2206. doi:10.1001\/jama.2021.7489","DOI":"10.1001\/jama.2021.7489"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"5. Basic-Jukic N, Ivo J. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis. 2021;23(4):e13628. doi:10.1111\/tid.13628","DOI":"10.1111\/tid.13628"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"6. Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385(7):661-662. doi:10.1056\/NEJMc2108861","DOI":"10.1056\/NEJMc2108861"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"7. Bertrand D, Lemee V, Laurent C, et al. Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients. Am J Transplant. 2022;22(5):1498-1500. doi:10.1111\/ajt.16954","DOI":"10.1111\/ajt.16954"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"8. Charmetant X, Espi M, Barba T, et al. Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine. Am J Transplant. 2022;22(5):1442-1450. doi:10.1111\/ajt.16990","DOI":"10.1111\/ajt.16990"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. Bray RA, Lee JH, Brescia P, et al. Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins. Transplantation. 2021;105(1):79-89. doi:10.1097\/TP.0000000000003524","DOI":"10.1097\/TP.0000000000003524"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. Danthu C, Hantz S, Dahlem A, et al. Humoral response after SARS-CoV-2 mRNA vaccination in a cohort of hemodialysis patients and kidney transplant recipients. J Am Soc Nephrol. 2021;32(9):2153-2158. doi:10.1681\/ASN.2021040490","DOI":"10.1681\/ASN.2021040490"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. Friedman MA, Curtis JR, Winthrop KL. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021;80(10):1255-1265. doi:10.1136\/annrheumdis-2021-221244","DOI":"10.1136\/annrheumdis-2021-221244"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T08:23:37Z","timestamp":1671438217000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/11\/0\/1022\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2022.0261","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}